Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°£°æº¯ ȯÀÚ¿¡¼­ ¸»ÃʽŰ溴ÁõÀÇ ÀÓ»óÀû Ư¼º°ú ½Å°æÀüµµ°Ë»ç ¼Ò°ß Clinical Characteristics and Nerve Conduction Study Findings in Peripheral Neuropathy of Patients with Liver Cirrhosis

´ëÇѼÒÈ­±âÇÐȸÁö 2003³â 41±Ç 6È£ p.486 ~ 492
¼Ò¼Ó »ó¼¼Á¤º¸
ÃÖÀ±Á¾/Choi YJ ¹é¼ø±¸/¼®±âÅÂ/±èÁ¤¹Î/Áö¸í°ü/±èÇö¼ö/À̵¿±â/±Ç»ó¿Á/¹Ú±âö/ÀÌÁö¿ë/¹è¼±¿ì/Baik SK/Suk KT/Kim JM/Je MG/Kim HS/Lee DK/Kwon SO/Park KC/Lee JY/Bae SW

Abstract

Background/Aims: In liver cirrhosis, symptoms such as paraesthesia and numbness are associated with peripheral neuropathy ('hepatic neuropathy'). The prevalence and nerve conduction study (NCS) of hepatic neuropathy have not been reported yet in Korea. This prospective study was designed to evaluate the prevalence, clinical characteristics, and NCS of hepatic neuropathy, and to compare peripheral neuropathy of alcoholic cirrhosis with that of nonalcoholic cirrhosis. Methods: Seventy-three patients with liver cirrhosis underwent neurological evaluations including a history and neurological examinations relevant to the peripheral nervous system. NCS was performed in all subjects. Results: Peripheral neuropathy was found in 53.4% of the patients. Sensory neuropathy was observed more frequently than motor neuropathy on NCS. Overall, the pattern of neuropathy was axonal degeneration. There was no difference in the characteristics of peripheral neuropathy between the patients with alcoholic cirrhosis and the patients with nonalcoholic cirrhosis. Among 29 patients with neurologic symptom and sign, 22 patients (76%) showed an abnormality in NCS. Conclusions: The prevalence of peripheral neuropathy is 53.4%. This study suggests that symptoms such as numbness or paraesthesia in patients with cirrhosis are related to peripheral neuropathy.


¸ñÀû: °£°æº¯ ȯÀÚÀÇ °¨°¢ ÀÌ»óÀº ¸»ÃʽŰ溴Áõ°ú ¿¬°üÀÌ ÀÖÀ¸¸ç, °¨°¢½Å°æÀÇ Ãà»èº¯¼ºÀÌ ±× Ư¡À¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. ¾ÆÁ÷ ±¹³»¿¡¼­´Â °£°æº¯ ȯÀÚ¿¡¼­ ¸»ÃʽŰ溴ÁõÀÇ À¯º´·ü ¹× ¾ËÄÚ¿Ã ¶Ç´Â ±âŸ¿øÀο¡ µû¸¥ ÀÓ»óÀû Ư¼ºÀÇ Â÷ÀÌ°¡ º¸°íµÈ ¹Ù°¡ ¾ø´Ù. ÀÌ¿¡ º» ¿¬±¸ÀÇ ÀúÀÚµéÀº ù°, ½Å°æÇÐÀû Áõ»ó ¹× ¡ÈÄ¿Í ½Å°æÀüµµ°Ë»ç¸¦ ÅëÇØ ±¹³» °£°æº¯ ȯÀÚ¿¡¼­ ¸»ÃʽŰ溴ÁõÀÇ À¯º´·ü°ú ÀÓ»óÀû Ư¼º ¹× ½Å°æÀüµµ°Ë»çÀÇ Æ¯¼ºÀ» »ìÆ캸°í, µÑ°, ¾ËÄڿüº °£°æº¯°ú ºñ¾ËÄڿüº °£°æº¯¿¡¼­ ¹ß»ýÇÑ ¸»ÃʽŰ溴ÁõÀÇ Æ¯¼ºÀ» ºñ±³ÇÏ°íÀÚ Çß´Ù. ´ë»ó ¹× ¹æ¹ý: °£°æº¯À¸·Î Áø´ÜÇÑ 73¸íÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î ½Å°æÇÐÀû Áõ»óÀÇ ¹®Áø, ½Å°æÇÐÀû °Ë»ç ¹× ½Å°æÀüµµ°Ë»ç(nerve conduction study)¸¦ ½Ç½ÃÇÏ¿´´Ù. °á°ú: ½Å°æÇÐÀû Áõ»ó¡¤Â¡ÈÄ ¹× ½Å°æÀüµµ°Ë»ç¿¡ ±âÃÊÇÑ °£¼º ¸»ÃʽŰ溴Áõ(hepatic neuropathy)ÀÇ À¯º´·üÀº 30.1%(22/73)¿´À¸¸ç, ¹«Áõ»ó ¸»ÃʽŰ溴ÁõÀ» Æ÷ÇÔÇÑ ¸»ÃʽŰ溴ÁõÀÇ À¯º´·üÀº 53.4%(39/73)¿´´Ù. °£¼º ¸»ÃʽŰ溴ÁõÀÇ ÁÖ Áõ»óÀº °¨°¢½Å°æ °ü·Ã Áõ»ó°ú Áøµ¿°¨°¢ °á¼ÕÀ̾ú°í, ºñº¹½Å°æÀÇ °¨°¢ ½Å°æÈ°µ¿ÀüÀ§ ÁøÆøÀÇ °¨¼Ò°¡ °¡Àå ÈçÇÑ ½Å°æÀüµµ°Ë»ç»óÀÇ ÀÌ»ó ¼Ò°ßÀ̾ú´Ù(47%, 34/73). ½Å°æº´ÁõÀÇ Àü¹ÝÀûÀÎ ÇüÅ´ °¨°¢½Å°æÀÇ Ãà»èº¯¼ºÀ̾ú´Ù. Ç÷û ¾ËºÎ¹Î°ªÀº ¸»ÃʽŰ溴ÁõÈıº¿¡¼­ ¸»ÃʽŰ溴ÁõÀÌ ¾ø´Â ±ºº¸´Ù ³·¾ÒÀ¸¸ç ºñº¹½Å°æÀÇ °¨°¢ ½Å°æÈ°µ¿ÀüÀ§ ÁøÆø°ú ¾çÀÇ »ó°ü°ü°è°¡ ÀÖ¾ú´Ù(r=0.329, p<0.01). °£°æº¯ÀÇ ¿øÀÎ ¹× ½ÉÇÑ Á¤µµ¿Í ¸»ÃʽŰ溴ÁõÀÇ ¹ß»ýÀº °ü·ÃÀÌ ¾ø¾ú´Ù. µÎ°³ ÀÌ»óÀÇ ½Å°æÇÐÀû Áõ»óÀ̳ª ¡ÈÄ°¡ ÀÖ´Â ±ºÀÇ ½Å°æÀüµµ°Ë»ç ÀÌ»ó ºñÀ²Àº 76%·Î Áõ»óÀ̳ª ¡ÈÄ°¡ ¾ø¾ú´ø ±ºÀÇ 39%º¸´Ù ³ô¾Ò´Ù(p<0.001). ¾ËÄڿüº °£°æº¯°ú ºñ¾ËÄڿüº °£°æº¯¿¡¼­ ¹ß»ýÇÑ ¸»ÃʽŰ溴ÁõÀº À¯º´·ü µîÀÇ ÀÓ»óÀû Ư¼ºÀÇ Â÷ÀÌ´Â ¾ø¾ú´Ù. °á·Ð: ¸»ÃʽŰ溴ÁõÀÇ À¯º´·üÀº 53.4%¿´°í, ½Å°æÇÐÀû Áõ»óÀ̳ª ¡ÈÄ°¡ ÀÖ´Â °£°æº¯ ȯÀÚÀÇ ´ëºÎºÐ¿¡¼­ ½Å°æÀüµµ°Ë»çÀÇ ÀÌ»óÀ» º¸¿´´Ù. µû¶ó¼­ ¼Õ¡¤¹ß Àú¸² µîÀÇ Áõ»óÀ̳ª ½Å°æÇÐÀû °Ë»çÀÇ ÀÌ»óÀº ´ëºÎºÐ ¸»ÃʽŰ溴Áõ°ú °ü·ÃÀÌ ÀÖ´Â °ÍÀ¸·Î ÆǴܵȴÙ.

Å°¿öµå

Liver cirrhosis; Peripheral nervous system diseases; Neural conduction; Alcohols; °£°æº¯; ¸»ÃʽŰ溴Áõ; ½Å°æÀüµµ°Ë»ç; ¾ËÄÚ¿Ã

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

MEDLINE
KCI
KoreaMed
KAMS